l carnitine hyperammonemia Quantitative systems pharmacology Model to characterize valproic acid-induced and the effect of L-carnitine supplementation Hyperammonemia in review: pathophysiology, diagnosis,
Description
M., & Trexler, E
The prevalence of CHE was reported to be between 30% and 84% in patients with cirrhosis [7,12,13]
Clinical Evidence and Effect Evaluation Limited clinical research Most of the existing studies are small-sample and non-controlled trials
Tanpa karnitin yang cukup, lemak tidak dapat masuk ke mitokondria dengan efektif, sehingga tubuh akan kekurangan energi dan penumpukan lemak mungkin terjadi
